BCYRN1 was increased in non-small cell lung cancer (NSCLC), and its downregulated expression could suppress NSCLC cell proliferation and cell cycle progression by inhibiting the Wnt/βcatenin pathway [4]. The gene discussed is BCYRN1; the disease is non-small cell lung carcinoma.